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Abstract: - The prevalence of Type 2 diabetes mellitus (T2DM) has recently been elevated due to lifestyle changes and other factors. 
T2DM is linked to the prevalence of different associated conditions, one of which is gestational diabetes mellitus (GDM). GDM is 
a common condition of expectant mothers, defined as glucose intolerance, noted to be a predictor of the development of T2DM after 
pregnancy. In numerous studies regarding GDM, ABO blood groups and other risk factors are being investigated for its correlation 
in the development of T2DM. In this study, the researchers determined the prevalence and risk factors of T2DM as well as its 
distribution among ABO blood groups in mothers with a history of GDM in Metro Manila, Philippines. The researchers collected 
data from mothers within the inclusion criteria using an online survey with a quantitative, non-experimental, cross-sectional approach 
and non-probability purposive sampling to obtain results. The statistical measures utilized were computation of BMI, Means and 
Standard Deviations of BMI, One-Way Analysis of Variance of the BMI, prevalence equation, odds ratio, and multivariate logistic 
regression. The results showed that 49.01% or almost half of the participants that had GDM have developed T2DM. Participants 
with the B phenotype are discovered to be more likely to develop T2DM, especially those with family history of diabetes and high 
cholesterol. It is also reported that even with high physical activity, mothers with GDM are still at risk for development of T2DM. 
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Due to the epidemiologic shift of the population 
towards associated lifestyle changes, among other factors, the 
global prevalence of Type 2 diabetes mellitus or T2DM has 
more than doubled and the age of onset of the disease has also 
become younger (Zhu & Zhang, 2016). T2DM, traditionally 
known to be an adult-onset diabetes due to causes such as  
 
 
Resistance to insulin and insufficient insulin 
production, has become more common and has shown to be 
linked with other types of disorders. By 2030, the incidence 
of diabetes mellitus is anticipated to rocket to 439 million, 
which represents 7.7% of the global adult population aged 20-
79 years old (Chen et al., 2011). In parallel with the emerging 
rise of T2DM worldwide, the incidence of gestational 
diabetes mellitus (GDM) has also been increasing (Karagoz 
et al., 2015). 
 
GDM is a common condition that is defined as glucose 
intolerance first recognized during pregnancy (Shimodaira et 
al., 2015). GDM is not only associated with adverse 
pregnancy complications such as birth trauma, preeclampsia, 
dystocia, and other metabolic disorders, but GDM also 
predicts the development of diabetes mellitus postpartum. 
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GDM also strongly reflects the underlying T2DM epidemic 
(Karagoz et al., 2015). 
 
In other studies, relationships between GDM and ABO blood 
groups are also being explored. The ABO blood group system 
is a classification of blood groups based on the presence or 
absence of A and B antigens. ABO antigens can have an effect 
in biomarkers which have been linked to the insulin resistance 
and development of T2DM. To date, several studies have 
examined the correlation between diabetes and ABO blood 
groups, particularly the relationship between GDM and ABO 
blood groups but the findings among these studies were 
inconsistent (Sapanont et al., 2019). Likewise, there is an 
evident lack of studies to date that focus on the Filipino 
population. 
 
In this study, the researchers determined the prevalence of 
T2DM in Filipino GDM mothers and investigated if there is 
an ABO blood group phenotype that is more significantly at 
risk of developing T2DM from GDM. Data was delimited to 
T2DM that was associated only with GDM among maternal 
ABO blood groups, specifically: Blood Group A, Blood 
Group B, Blood Group AB, and Blood Group O. The 
researchers focused on gathering information from mothers 
aged 25 years old to 59 years old who are presently living in 
Metro Manila, Philippines. The respondents were mothers 
who have had GDM at least once during their pregnancy 
period. 
 
1.2. Objectives of the Study 
The primary objective of this study was to determine 
the prevalence of developed T2DM in mothers with a history 
of GDM, as well as its distribution among ABO blood groups, 
and associated risk factors. 
 
This study specifically aimed to: 
 Determine the prevalence of mothers with T2DM who 
were diagnosed with GDM during pregnancy; 
 List possible risk factors in the development of T2DM 
from GDM based on participant profiles; 
 Determine the prevalence and distribution of GDM 
mothers who developed T2DM per major Blood Groups 
A, B, AB, and O; and 
 Identify if a certain major blood group is more 
significantly at risk of developing postpartum T2DM 
after being diagnosed with GDM compared to other 
blood groups based on the prevalence, and the 
associated risk factors. 
 
1.3. Problem Statement 
There has been an increase in the development of 
T2DM in recent years due to shifts in lifestyle and it has 
become a global burden (Zhu & Zhang, 2016). GDM is 
known to be a risk factor in developing T2DM (Karagoz et 
al., 2015); however, there are only limited studies regarding 
the associated risk factors in developing T2DM among 
mothers who were previously diagnosed with GDM, 
especially in the Philippines. The association of diabetes with 
ABO blood groups and the risk factors for T2DM in mothers 
previously diagnosed with GDM is still yet to be established. 
 
1.4. Hypotheses of the Study 
The following are the hypotheses of this study: 
 The development of T2DM was prevalent in mothers 
who were diagnosed with GDM. 
 Excess body weight or high body mass index (BMI), 
hypertension, high cholesterol, family history of 
diabetes, and physical inactivity were risk factors in 
developing T2DM among different ABO blood groups. 
 The prevalence and distribution of GDM mothers who 
developed T2DM varied per major blood groups A, B, 
AB, and O. 
 Based on the gathered data on the distribution and 
associated risk factors, there existed a major blood 
group that was more significantly at risk of developing 
postpartum T2DM after being diagnosed with GDM as 
compared to other blood groups. 
 
1.5. Research Impediments 
The primary goal of this study is centered on 
identifying the prevalence of having T2DM among mothers 
diagnosed with GDM and the probability of developing 
T2DM in relation to their ABO blood groups and risk factors. 
 
The researchers noted the following scope of the study: (a) 
Only T2DM that is associated with GDM among ABO blood 
groups was addressed in this study. (b) The blood groups 
included are Blood Group A, Blood Group B, Blood Group 
AB, and Blood Group O. (c) The risk factors emphasized 
were high BMI, family history of diabetes, hypertension, high 
cholesterol, and physical inactivity only. (d) Mothers aged 25 
to 59 years old who have had GDM at least once during their 
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pregnancy years were the participants of the study. (e) The 
collected data were provided by the participants assuming that 
they delivered honest responses. (f) Data was collected from 
respondents residing in Metro Manila only. (g) As the study 
was conducted through an online survey, consent was also 
sought from the participants. (h) Verification of data was only 
through the respective proofs that were given by the 
respondents such as identification card, 
electric/phone/water/internet/cable bills, medical certificates, 
and recent blood sugar test results. 
 
The researchers established the following delimitations: (a) 
Mothers who are aged 24 and below were not included in the 
study since according to the American Diabetes Association 
or ADA, onset of GDM starts at 25 years old or above. 
Similarly, mothers 60 years old and above were not included 
in this study as prescribed to the researchers. (b) Participants 
who were not willing to provide personal information and 
medical information were also excluded. (c) Participants who 
reside outside Metro Manila were rejected for they will be 
outside the scope of the study. (d) Individuals with Type 1 
diabetes mellitus were not eligible to participate since this 
study focuses solely on T2DM and GDM. (e) Individuals 
currently diagnosed with other conditions, except for 
hypertension and high cholesterol, were excluded since other 
comorbidities not discussed in this study may influence the 
diagnosis of T2DM. (f) Face-to-face interviews and surveys 
were not conducted; the need for this type of communication 
did not arise, so phone calls or online calls/meetings were not 
done. (g) Due to the restrictions brought about by the 
pandemic, and for the personal data security of the 
participants, thorough verification of the data provided was 
not feasible. (h) Should the participants feel hesitant in 
participating before the submission of their answers on the 
survey, they were free to withdraw their involvement in the 
research. (i) The researchers did not include demographic and 
perception questions from the Diabetes Questionnaire used 
for the survey. (j) The risk factors emphasized in this study 
are based from the reviewed related literature in Chapter 2. 
(k) This study did not include specific data on when T2DM 
developed after being diagnosed with GDM during 
pregnancy. The years between the progressing of T2DM post 
GDM may be analyzed in a different kind of study.  
 
1.6. Significance of the Study 
The study will greatly benefit the following: 
To the Diabetic Community: 
For people who have experienced or are experiencing GDM, 
the data presented in this paper can provide awareness 
regarding the possibilities of developing T2DM based on their 
blood group, as well as the risk factors associated with it. The 
findings can help them adjust their ways of living accordingly 
so that they can reduce the risk of developing T2DM. 
 
To Allied Health Professionals: 
The specific aims of this research would aid the present and 
future physicians, especially the obstetrician-gynecologists. 
Through this research, they would be able to be more careful 
and observant on the follow-up of pregnant women, 
especially GDM mothers, as well as on the provision of a 
diagnosis early on. They would also be able to monitor 
women as soon as they are diagnosed, to provide aid 
immediately. 
 
To the People of the Academe and Laboratory Sciences field: 
The scientific findings gathered from this research would 
supplement the existing knowledge and skills of future 
medical technologists in the advanced laboratory diagnosis 
for effective monitoring, risk association, and management of 
GDM and T2DM. This would further contribute to the 
previous studies about the two diseases. It would also serve as 
a foundation for those interested in expanding the available 
information that would be presented in this research. 
 
To the General Public: 
This study is beneficial to society because ABO blood group 
phenotypes and GDM, among many factors, are associated 
with different adverse pregnancy outcomes and is also a 
strong predictor of developing T2DM postpartum. Through 
the facts and figures shown in this study, people would be 
educated about the prevalence and risk factors of mothers 
developing T2DM from GDM. If society is educated about 
such information, collective efforts to prevent development of 
T2DM among GDM mothers may be put into action.  
 
1.7. Definition of Terms 
The following key terms defined are used in the 
context of the study:  
ABO blood groups. Classification of blood based on the 
inherited characteristics of red blood cells which are 
differentiated based on the presence of antigens; the principal 
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groups of the ABO blood group are the following: Group A, 
Group B, Group AB, and Group O 
ABO gene. Gene responsible for determining a person's blood 
group. 
Antigen. Substance that is not recognized by the body which 
activates an immune response for the body to produce 
antibodies. 
Antibody. Protein produced by the immune system that 
responds when there is presence of foreign materials in the 
body usually called antigens.  
Diabetes Mellitus. Group of non-communicable metabolic 
diseases characterized by hyperglycemia which leads to 
defects in insulin activity categorized as Type 1 diabetes 
mellitus, Type 2 diabetes mellitus, other specific types of 
diabetes, and Gestational diabetes mellitus. 
Glucose intolerance. Condition of having an abnormality in 
the stability of the blood sugar that consists of both 
prediabetes and diabetes. 
Hyperglycemia. Defined as high levels of glucose in the blood 
Insulin. Hormone produced by the pancreas that functions by 
regulating the volume of glucose in a person’s blood. 
Insulin resistance. Phenomenon wherein the cells of the body 
are incapable of responding properly to insulin. 
Metabolic disorders. Disorders that occur when the 
metabolism is disrupted due to abnormal chemical reactions 
which result in an excess or a deficiency of substances in the 
body such as carbohydrates, lipids, and amino acids. 
Polycystic Ovarian Syndrome (PCOS). Condition in which 
hormonal imbalance is present among women of reproductive 
age. 
Postpartum. Phase after the birth of a baby or after childbirth. 
Risk Factors. Any aspect, component, or influence which 
increases the chance of a person from developing a disease or 
condition. 
 
II.     REVIEW OF RELATED LITERATURE 
 
This chapter contains reviewed related literature that 
serves as the foundation of this study.  
 
2.1. Gestational Diabetes Mellitus (GDM) 
 
 2.1.1. Pathophysiology: 
Glucose intolerance with onset or first recognition during 
pregnancy is termed as gestational diabetes mellitus, also 
known as GDM. During pregnancy, usually between 24 and 
28 weeks of gestation, observable signs and the onset of GDM 
arise (WHO, 2016). It has been established from various 
researches that during pregnancy, the placenta produces 
hormones such as the human placental growth hormone and 
human chorionic somatomammotropin that make the body 
resistant to the effect of the insulin. These hormones work 
together in order for the placenta and uterus to improve 
vascularization and regulate the body’s metabolism and 
support the fetus with a sufficient amount of glucose. Besides 
these hormones being altered in levels, estrogen, 
progesterone, prolactin, cortisol, human chorionic 
gonadotropin, leptin, TNF-alpha, and oxidative stress 
biomarkers are also altered. Insulin is a hypoglycemic agent 
that helps glucose levels in the body to maintain its 
equilibrium. However, hormones that are elevated during 
pregnancy to help the fetus grow partially blocks the action of 
the insulin which is generally secreted by the pancreas. 
Without enough insulin production, this phenomenon results 
in building up of glucose in the blood far more than a pregnant 
body normally needs (ADA, n.d.). This is how it is considered 
as a category of hyperglycemia or increased plasma glucose 
levels caused by an imbalance of hormone levels (Diabetes 
Care, 2015). The thirteenth up until the seventeenth week of 
pregnancy marks the resistance of insulin which nearly 
decreased in half of the normal level because of too much 
glucose production in the body in order to meet the demands 
of the fetus. This process which involves an increase in the 
nutritional needs of the fetus can make the pregnant woman 
at risk for diabetes because of uncontrolled levels of glucose 
in the body that the insulin cannot handle (Barbour et al., 
2018). 
 
In recent years, there is a rising prevalence in patients 
developing GDM. It has become one of the leading causes of 
mortality and morbidity worldwide which is a risk for both 
the mother and the offspring (Li et al., 2020). Despite that, it 
has been proven that patients diagnosed with GDM can 
normally return to normal conditions in the postpartum 
period. However, according to a study made by Barbour, 
Buschur, & Stetson (2018), about 70% of diagnosed patients 
develop Type 2 diabetes mellitus or T2DM later in time. 
 
2.1.2. Vulnerable populations: 
GDM is a non-communicable disease that can develop due to 
the production of several hormones as mentioned earlier. The 
main and root cause of GDM is unknown but it has been 
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established that it can occur to all expectant women since all 
can experience the shift in hormone production. Due to its 
unknown causes, several factors that can increase the risk of 
GDM were established such as having an unhealthy lifestyle 
and family history of diabetes. 
 
Excess body weight or high Body Mass index (BMI): 
According to the Centers for Disease Control and Prevention 
or CDC, obesity can underlie several poor health outcomes of 
individuals. It increases the risk of serious health conditions 
including diabetes. In a study conducted by Larrabure-
Torrealva et al. (2018), obesity along with several factors such 
as BMI are highly associated with GDM. 
 
According to a study by Heude et al. (2012), women with 
higher BMI pre-pregnancy are more likely to develop 
gestational hypertension and GDM. Similarly, a study 
published by Gaillard et al. (2013) regarding risk factors and 
outcomes of maternal obesity has shown that excessive 
gestational weight increases the risk of GDM along with other 
adverse maternal outcomes. 
 
Family history of diabetes: 
Since the cause of GDM is unknown, several studies have 
claimed that a family history of diabetes is associated with the 
risk of developing GDM. A meta-analysis of 81 relevant 
articles in 2017 by Kiani et al., showed that 31% of the articles 
have claimed that family history of diabetes is a risk factor of 
GDM. Similarly, a study showed that family history of 
diabetes could be a distinct predictor of GDM in Taiwanese 
pregnant women (Lin et al., 2016). Also, according to the 
aforementioned study by Larrabure-Torrealva et al. (2018), 
the history of diabetes increases the odds of developing 
diabetes by 1.5-fold compared to those who have no family 
history of diabetes. 
 
Advanced maternal age: 
The occurrence of GDM is also correlated to age. As stated 
by the CDC, women who are more than 25 years old during 
gestation are at risk for developing GDM. One study found 
that pregnant women at the age of 25 years onwards indicate 
a relative increase of risk in having GDM (Duman, 2015). In 
support of this, a meta-analysis of twenty-four studies was 
conducted by Li et al. (2020), showed that age is directly 
proportional to GDM, which means that as the age increases, 
the risk for developing GDM also increases. 
Other risk factors: 
A notable risk factor mentioned by the CDC in developing 
GDM is the race. The results from the study by Hedderson, 
Darbinian, and Ferrara (2010), showed that Asian Indian 
women have the highest prevalence of GDM. In addition, 
Asian subgroups namely Chinese, Southeast Asians, 
especially Filipinos, also have a high prevalence of GDM, 
along with Mexicans and Pacific Islanders compared to white 
and black women. CDC also mentioned that having 
polycystic ovarian syndrome (PCOS) can be a risk factor. 
This was supported by a study in 2015, stating that women 
who were diagnosed with PCOS have two-fold increased 
odds of developing GDM compared to those who do not have 
nor have symptoms of PCOS (Pan et al., 2015). 
 
 2.1.3 Gestational Diabetes Mellitus in the Philippines: 
Based on a study by Tan (2015), diabetes has been increasing 
at an alarming rate within Asian countries and the Philippines 
is not an exemption. As of 2015, the prevalence of diabetes in 
the country has been gradually increasing due to factors such 
as lifestyle and diet. It has been found out that the factors that 
contributed to this effect is the increasing dependence on 
electronic devices and also the sedentary lifestyle of most 
Filipinos (Tan, 2015). The study concluded with the 
Philippines needing a fundamental and transformative change 
in diabetes awareness and proper lifestyle to lessen the 
accumulating numbers.  
 
There are only a few available studies that were conducted in 
the Philippines pertaining to GDM, so data from other Asian 
countries were compared. One of the few studies that can be 
found that has the data of prevalence of GDM in the 
Philippines is a study by Litonjua et al. in 1996 (Pineda-Cortel 
et al., 2018). According to that study, it was determined that 
the prevalence of GDM in the Philippines is at 14%. Another 
study done by the University of Santo Tomas Hospital-
Clinical Division, also known as USTH-CD, identified that 
the GDM prevalence of the country was 7.5%.  
 
A correlation between GDM and increasing BMI, and family 
history of diabetes was also found in the study (Pineda-Cortel 
et al., 2018). Further studies should be conducted about GDM 
to widen the information and statistics in the Philippines. As 
of now, studies only pertain to the correlation between the risk 
factors of GDM and its prevalence in the Philippines. 
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2.2. Type 2 Diabetes Mellitus (T2DM) 
2.2.1. Pathophysiology: 
Type 2 diabetes mellitus, also known as T2DM, is a 
chronic metabolic disorder characterized by insulin 
sensitivity as a consequence of a decline in insulin secretion, 
insulin resistance, and pancreatic beta-cell failure (Olokoba et 
al., 2012). 
Initially, there is a sufficient increase in insulin secretion by 
the pancreatic beta-cells to maintain the body’s glucose levels 
(Goyal & Jialal, 2020). In situations where resistance to 
insulin is prevalent, the mass of the pancreatic beta-cells 
undergoes transformation to increase the insulin supply in 
order to sustain its excessive demand (Baynest, 2015). As 
these beta-cells change on the onset of T2DM, the insulin 
secretion is impaired and is unable to meet the glucose 
homeostasis. This decrease in glucose responsiveness then 
leads to hyperglycemia (Goyal, 2020). Impaired insulin 
secretion is progressive. This could be due to the continuous 
decline in the rate of cellular secretion of the beta-cells, 
decrease in beta-cell mass, or both, if left untreated (Cantley 
& Ashcroft, 2015). The progression of impaired insulin 
secretion is known to affect the long-term blood glucose 
levels of the body as well as cause complete pancreatic beta-
cell dysfunction (Cerf, 2013). 
 
T2DM can also result from insulin resistance (Cerf, 2013). It 
is a condition wherein there is a deficit in biologic response 
to insulin stimulation of the major target organs such as the 
liver and muscles (Freeman et al., 2020). The attention on the 
molecular mechanism of insulin has elucidated how insulin 
resistance is related to risk factors such as genetics. Genetic 
factors that affect insulin signals are: insulin receptor, insulin 
receptor substrate gene polymorphism, polymorphisms of 
genes such as beta-3 adrenergic receptor gene, and 
uncoupling protein gene. These are associated with the 
promotion of insulin resistance as well as obesity in patients 
(Kaku, 2010). Recent studies also suggest involvement of 
adipocyte-derived substances called adipokines, 
inflammation, incretin resistance, and hyperglucagonemia in 
insulin resistance (Goyal & Jialal, 2020). 
 
2.2.2. Vulnerable populations: 
The development of T2DM has a lot of risk factors; some of 
which include unhealthy lifestyle, coexisting diseases, and 
family history. Although T2DM appears later in life as it is 
adult-onset, the associated risk factors usually start at a 
younger age and thus, contribute to the development of the 
disease upon aging. 
 
Overweight and obese populations (high BMI): 
According to the WHO, excessive body fat content is the 
strongest risk factor for T2DM. Therefore, people who are 
overweight or obese and are physically inactive are at a large 
risk of developing T2DM. Relatively, from a study done by 
Kennerly & Kirk (2018), it was shown that diagnosed T2DM 
adults all have low rates of physical activity and are living a 
sedentary lifestyle. BMI is directly associated with being 
obese and overweight, hence, it has widely known that people 
with higher BMI are more at risk of developing T2DM. The 
BMI computation is used in determining the classification of 
the body fat in accordance with their height and weight. 
 
People with family history of diabetes: 
Diabetes mellitus is hereditary and people with first-degree 
relative/s suffering from T2DM have a 40% risk of 
developing diabetes (Wu et al., 2016). Papazafiropoulou et al. 
(2017), have established that the risk of developing T2DM 
significantly increases up to 2-4 times if both or one of the 
parents also have this disease, and that many of the patients 
suffering from the disease have family members who have it 
as well. According to Aasbjerg et al. (2020), even patients 
with second-degree relatives, even half-siblings sharing a 
common mother or father, have increased risk of developing 
diabetes. However, this may also be attributed to other 
environmental factors. 
 
All age groups: 
Although T2DM is otherwise termed as adult-onset diabetes, 
presently there are also occurrences of cases of this disease in 
the younger populations (Wu et al., 2014). According to the 
WHO, evidence suggests that this rising trend of T2DM in the 
younger generation, particularly children, can be attributed to 
the increase in consumption of sugars and rampant obesity. 
 
Mothers who had GDM: 
Gestational diabetes, according to Rice et al. (2012), “may 
unmask a predisposition to type 2 diabetes.” Studies from 
Aroda et al. (2015), and Herath, Herath, & Wickremasinghe 
(2017), have proven that GDM mothers developed T2DM 
later in life. Aroda et al. (2015) stated that there is a 48% 
higher chance of developing T2DM, meanwhile Herath, 
Herath, & Wickremasinghe (2017) claimed that the 
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development of T2DM is tenfold higher in GDM mothers. In 
support, Mahzari et al. (2018) stated that “older, multigravid, 
and multiparous and who have a prior history of GDM” are at 
risk of developing T2DM.  However, proper risk prediction 
techniques for the development of T2DM in GDM mothers 
are yet to be established.  
 
People with hypertension: 
Diabetes and hypertension have similarities when it comes to 
risk factors and both conditions often co-exist. High blood 
pressure along with other factors such as age, ethnicity, 
obesity, etc. were identified as risk factors for diabetes 
(American Disease Association, 2014). As evidenced from a 
study in Korea by Kim, Lim, Choi, and Park (2015), wherein 
after 8-year follow up, 14.7% of the subjects developed 
T2DM from subjects that were normotensive, 
prehypertensive and hypertensive. Thus, the authors claimed 
that prehypertension and hypertension are considered to be a 
risk factor for diabetes regardless of baseline glucose status, 
gender, and BMI. It should be noted, however, that the study 
had several limitations such as age and the period during the 
follow-ups. In addition, systemic insulin resistance also 
manifests in 50% of patients who have high blood pressure 
(Lastra et al., 2013). On the contrary, another study by Sun et 
al. (2019) wherein they established that T2DM may be a risk 
factor for hypertension but such a relationship from 
hypertension towards T2DM was unlikely.  
 
People with high cholesterol: 
Abnormal levels of cholesterol in the blood, specifically 
serum triglyceride and its lipoprotein carriers – low-density 
lipoprotein (LDL), intermediate-density lipoprotein (IDL), 
very low-density lipoprotein (VLDL), and high-density 
lipoprotein (HDL), are constantly associated with T2DM 
which is a risk factor of coronary heart disease (Grundy et al., 
2019). In a study by Feingold (2020), 30-60% of T2DM 
patients present a significant increase in serum triglyceride, 
VLDL, and IDL values while there is a decrease in HDL, the 
good cholesterol. An increase in small dense LDL, a 
lipoprotein that promotes buildup of fats and cholesterol, is 
also noticeable. However, high values of LDL, the bad 
cholesterol, should not be used as the only indicator of 
diabetes mellitus or coronary heart disease, as confirmed by 
the latest guidelines of the American Heart Association 
(2020). Feingold (2020) also mentioned that the above normal 
levels of blood cholesterol are especially common since high 
prevalence of T2DM patients are insulin resistant, obese, and 
have experienced metabolic syndrome. Furthermore, 
conclusive results stated by Chehade and colleagues (2013) 
reported that the blood cholesterol levels of T2DM patients, 
specifically plasma triglyceride, are markedly increased while 
the HDL is decreased for about 19% of men and 17% of 
women compared to 9% and 8% of the nondiabetic controls 
for men and women respectively.  
 
It is also important to mention that high levels of blood 
cholesterol and other lipids may be present or absent years 
before the diagnosis of T2DM as reported by Tan & 
MacEachern in their 2020 study. 
 
 2.2.3. T2DM in the Philippines: 
Globally, T2DM has been considered as one of the most 
difficult issues of public health, especially in developing 
countries (Ng, 2020). According to the reports of the 
International Diabetes Federation, the prevalence of diabetes 
in the Philippines has increased from 3.4 million in 2010 to 
3.9 million in 2020. 
 
There are only several recent studies about T2DM in the 
Philippines that are available and conducted. One of the 
studies that can be found with the data of the incidence and 
prevalence of T2DM in the country was conducted by Soria 
et al. (2009). They have concluded that there is a disturbing 
growth of diabetes in the Philippines that calls for early 
vigorous intervention for its prevention and management. 
They have observed that the incidence of T2DM for 9 years 
(from 1998 to 2007) was 16.3%, and the prevalence was 
28.0%. The study recommends the use of a 2-hour post-
glucose load test apart from the fasting blood glucose test for 
people with diabetes to help in the prevention and 
management of T2DM in the country.  
 
In a study by Aoto et al. (2019), they made a conceptual model 
for the quality of life among people with T2DM in the 
Philippines. In their study, they have observed that there is no 
direct correlation with social factors and the quality of life of 
people with T2DM. It indicated that in areas of low-income 
in the country, the quality of life of people with T2DM has no 
correlation with their social and economic status. It was 
observed that Filipinos give importance to understanding their 
disease and to integrating self-management of their disease 
into their daily lives. 
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2.3. T2DM in Relation to GDM 
Due to the rising epidemiologic prevalence of 
diabetes mellitus affecting people at different life stages and 
populations, there has been an increase in synthesizing data 
that correlates GDM and T2DM, but they are still limited. 
GDM has been closely linked and is demonstrated to be 
correlated to a subsequent development of T2DM. A study 
published by Herath, Herath, & Wickremasinghe (2017), 
shows that women who have experienced GDM have a ten-
fold higher risk of developing T2DM during a 10-year follow 
up period, than women who have not experienced GDM. This 
is further proven by the study conducted by Aroda and 
colleagues (2015), stating that women experiencing GDM 
have about 50% likelihood of developing T2DM in the 
ensuing years, and may also have recurrent GDM in a 
subsequent pregnancy. The point estimates vary depending on 
the duration of the women’s follow-up and also the population 
characteristics (Aroda et al., 2015). From the same study, it 
has also been proven that women who have experienced 
GDM with pre-existing risk factors can reduce the likelihood 
of developing T2DM with pre-diabetes intensive lifestyle 
modification or metformin treatment early on. This would 
reduce the likelihood of diabetes over the subsequent 10 years 
by 35–40%. Postnatal advising and check up on women are 
very much important, most especially to women who have 
experienced GDM. This is further strengthened by a 
systematic review and meta-analysis accomplished by 
Rayanagoudar et al. (2016). The information they have 
gathered in their study reveals that besides recognizing the 
risk factors, individualized postnatal counseling would 
greatly improve pregnancy-specific details such as GTT 
results, gestational age at GDM diagnosis, use of insulin, and 
complications such as preeclampsia, preterm birth, and the 
development of T2DM after GDM. The progression from 
GDM to T2DM was also very much emphasized in a study 
published by Mahalakshimi et al. (2014). The results of their 
study reveal that the development to T2DM occurs within a 
5-year period after delivery, and by 10 years, most of the 
women had already developed T2DM. These rates are 
possibly dependent on follow-up check-up of the participants. 
 
In a different study published by Eades and colleagues in 
2015, it has been discovered that women diagnosed with 
GDM and then developed T2DM, had a window time of about 
8 years between both diagnoses. This time period is important 
to consider in making decisions about lifestyle changes 
because that window of time allows women to have an 
intervention when their child is in an age that makes them less 
dependent already. Also, based on the findings of this study, 
overweight women, those with an HbA1c of over 42.1 mg/dL, 
those who used insulin during their pregnancy and those with 
FBG of 7.0 mmol/l and over, are to be considered as a priority 
for intervention because they have a higher risk of developing 
T2DM after being diagnosed with GDM (Eades et al., 2015). 
In a separate study conducted by Gunderson et al. (2015), 
high lactation intensity and lactating for a longer duration 
were independently associated with lower 2-year incidence of 
T2DM after GDM. 
 
Besides being correlated with weight and other risk factors, 
the association between GDM, T2DM, and ABO and Rh 
blood groups are also being observed for epidemiologic and 
genetic studies. This further proves the need to take note of 
patient history and to have regular postpartum check-ups, 
especially for women who have experienced GDM. 
 
2.4. ABO Blood Groups, Genetics, and Inheritance 
The ABO blood group system is a classification of 
the most basic blood groups based on A and B antigens 
present or absent on red blood cells (Shimodaira et al., 2016). 
There are four major blood groups which are the most dealt 
with in clinical practice, namely Blood Groups A, B, AB, and 
O (Choate, 2018).  
 
The clinical importance of ABO blood groups goes beyond 
transfusion medicine (Liumbruno & Franchini, 2013). In 
recent years, studies have shown great significance of ABO 
blood group system and its respective phenotypes in 
association with different diseases such as cancer (Zhang et 
al., 2014), dementia (Vasan et al., 2015), T2DM (Kamil et al., 
2010), and other non-communicable diseases.  
 
As mentioned, the four major blood groups consist of Group 
A, B, AB, and O. These are inherited from an individual’s 
biological parents just like any other genetic trait. The parents 
give a total of two ABO genes to their child. The ABO gene 
which is found in chromosome 9 accounts for the 
determination of what group of blood an individual would 
inherit (Kominato et al, 2020). A and B alleles are codominant 
while O alleles are recessive. This means that the presence of 
A and B antigens will be expressed on the red blood cell 
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whichever allele is present. However, the O alleles termed as 
recessive do not develop any ABO antigens. 
 
Table.1. refers to the possible genes an individual may inherit 
in accordance with their blood group. In a research study 
published by Groot and colleagues (2020), it purposely 
informs about how the ABO blood groups have been proven 
to play a key role in several inherited diseases like diabetes 
mellitus, healthy aging, and disease development. Therefore, 
the determination of ABO blood groups could be of benefit in 
individualized health maintenance and prevention of diseases. 
Certain blood groups may pose a lower risk of acquiring or 
developing a disease. For example, in an article written by 
Dean, L., MD (2012), it is revealed that in comparison to other 
blood groups, individuals with Blood Group O have a lower 
risk of acquiring pancreatic cancer and thromboembolic 
diseases.  
 
Table.1. ABO Blood Groups Genetic Combinations 
 
 Blood Group Possible Genes 
A AA or AO 




2.5. The Role of ABO Blood Groups in the Development 
of Non-communicable Diseases 
The ABO blood group plays a significant role not 
only in immunohematology but it also extends toward other 
non-communicable diseases. ABO antigens are commonly 
known for their expression on red blood cells; however, these 
expressions are also present in human cells, tissues, platelets, 
and vascular endothelium. Consequently, Liumbruno and 
Franchini (2013) claimed that ABO blood group has an 
involvement in the progress of cardiovascular, oncological, 
and other diseases. Their study involves different studies 
providing data regarding ABO blood group’s association to 
several non-communicable diseases. This includes coronary 
heart disease, since this blood group influences Von 
Willebrand Factor or VWF and especially factor VIII (FVIII) 
plasma levels. VWF and FVIII plasma levels are both 
prothrombotic risk factors that are the focus involving the 
influence that the ABO blood group system exerts on 
hemostasis (Franchini & Lippi, 2015). It is also noted that 
VWF levels are higher for non-O blood groups. This claim is 
supported by a study by Favaloro, Targher, and Lippi (2012), 
which also stated that there is a major influence that connects 
the ABO blood group to the plasma levels of the VWF factor 
VIII complex and supports the idea that normal Group O 
individuals have lower levels of VWF and FVIII than non-O 
individuals. Another study by Franchini and Lippi (2015) 
claimed that the plasma levels of both VWF and FVIII are 
approximately 25% higher in individuals of non-O blood 
group than normal Group O individuals. According to the 
study, the molecular basis for this claim is due to the identified 
presence of ABH antigenic structures that are found 
circulating in VWF that function to regulate the activity with 
the use of different degrees of glycosylation in this 
multifunctional protein. The study also claimed that high 
VWF-FVIII levels is a risk factor for coronary heart disease 
(Liumbruno and Franchini, 2013). This is supported by the 
meta-analysis by He, Wolpin, Rexrode, Manson, Rimm, Hu, 
and Qi (2012), which established that non-O blood groups 
have an 11% increase in the risk of developing coronary heart 
disease. In addition, venous thromboembolism also has an 
association towards ABO blood groups. One review by 
Welsby and Zhou (2014), conferred for the same findings as 
Liumbruno and Franchini (2013) stating the ABO blood 
group’s role in determining VWF and FVIII levels which 
increases the risk of having VTE for non-O blood groups. 
 
Until now, studies have reported several non-communicable 
diseases’ association with non-O blood groups. Cancer risk 
and ABO blood group are also heavily associated by other 
studies. Such studies were drawn to the suggested 
mechanisms which includes intercellular attachment, 
membrane signaling, inflammation, and immune monitoring 
of malignant cells are commonly investigated when it comes 
to correlations of ABO blood group and cancer risk (Fang et 
al. 2017). According to a study by Franchini and Lippi (2015), 
pancreatic and gastric cancers have the most consistent 
connection that has been found in cancers. 
 
Pancreatic cancer is considered to have genetic risk factors; 
however, the development mechanism of such disease is still 
yet to be known. Nonetheless, there are several findings with 
ABO blood group system’s genetic variation contributing to 
the development of pancreatic carcinogenesis explicitly 
Blood Group A and a lowered risk for Blood Group O (Pelzer 
et al. 2013).  
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A study conducted by Yu, Xu, Li, et al. (2019) investigated 
the relationship between ABO blood groups and gastric 
cancer. The results showed that individuals with Blood Group 
A had a higher risk of gastric cancer while individuals with 
Blood Group AB showed lower risk of having this cancer. For 
individuals with Blood Group B and Blood Group O, the risk 
of gastric cancer showed no significant difference.  
 
Different studies still state that further experimental studies 
need to be conducted to further investigate the relationship 
between the blood group and non-communicable diseases. As 
Franchini and Lippi (2015) stated that there is much 
information to be discovered especially about the molecular 
mechanisms that link the blood groups and non-
communicable diseases, for ABO blood typing can be an 
important factor in such diseases especially for cancer. 
 
2.6. ABO Blood Groups and Development of T2DM 
Due to the inheritable nature of the ABO blood 
groups, numerous studies are interested in finding out the 
exact mechanism that might contribute to the role of such 
blood groups to the development of T2DM. Several studies 
reported their findings on the possible association of the 
development of T2DM and ABO blood groups. According to 
Navabi, Hemmati, Shaahmadi, & Aghaei (2020), these two 
are connected and “mutually dependent” because of the 
“immunological and genetic basis” of the ABO blood groups 
and T2DM. Fagherazzi et al. (2014) stated that the 
mechanisms are yet to be known; however, it is believed that 
non-Group O individuals have higher levels of the von 
Willebrand factor complex. Likewise, there is an association 
between ABO blood groups and the levels of both the plasma 
soluble intercellular adhesion molecule 1 (ICAM-1) and 
tumor necrosis factor receptor 2 or TNF-R2. The 
aforementioned inflammatory markers are highly associated 
with the increased risk of the development of T2DM. E-
selectin and P-selectin were also identified as markers of 
increased risk (Legese, Abebe, & Fasil, 2020). These markers 
are reportedly influenced by the human ABO locus. In 
addition to these, Legese, Abebe, & Fasil (2020) stated that 
an increase in the inflammatory endothelial cytokines and C-
reactive protein (CRP) production in the liver can promote 
direct resistance to insulin. Similarly mentioned in the 
previously cited study is that the imbalances in the gut 
bacteria, which is influenced by the ABO blood groups, can 
also be a cause of insulin resistance. 
Fagherazzi et al. (2014) have mentioned that based on their 
cohort study composed of 82,104 women, those with Group 
A and B blood are more at risk. Studies by Meo, Rouq, 
Suraya, & Zaidi (2016) and Legese, Abebe, & Fasil (2020) 
arrived at results where Blood Group B are relatively more at 
risk. Meanwhile, Blood Group AB was said to be more at risk 
in the study of Mandal et al. (2018). Blood Group A, on the 
other hand, was more at risk as stated in the study of Navabi, 
Navabi, Hemmati, Shaahmadi, & Aghaei (2020). All these 
four studies have results that indicated Blood Group O as the 
blood group with the lowest risk. These studies were 
conducted in France, Saudi Arabia, Ethiopia, India, and Iran 
respectively.  
 
Based on these reviewed literatures, although it is evident that 
there is a link between ABO blood groups and the 
development of T2DM and that having GDM is a risk factor 
for the development of T2DM, there are still inconsistent 
results in this field of study, particularly in which blood group 
is more at risk and what makes the mothers more at risk of 
developing GDM or T2DM. At present, literature that 
explores the relation of ABO blood group and development 
of T2DM from GDM in the Filipino population is very 
inadequate as papers mostly tackle specifically the prevalence 
and development of GDM or T2DM and not the development 
of T2DM after GDM. 
 




Fig.1. Theoretical Model. 
 
The theory used for this study is the Wheel Theory 
(Fig. 1). This theory was developed by Mausner and Kramer 
in 1985. It stipulates that a disease has a central core which 
involves genetic and peripheral factors such as social, 
psychological, and biological factors (Green & Johnson, 
2013). It can be applied in this research since such factors—
behavioral/psychological, social, and genetic factors are all 
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related to the development of T2DM (Navabi, Navabi, 
Hemmati, Shaahmadi, & Aghaei, 2020). The researchers are 
to apply the theory and gather health-related information from 
the participants, apply statistical analysis, and identify 
essential factors correlated to the development of T2DM. 
 





Fig.2. Conceptual Framework 
The conceptual framework used for the structure of 
this paper is presented in Figure 2. Since it has been 
established, as mentioned in the review of literatures, that 
blood groups, having a history of GDM, having a family 
history of T2DM, lack of physical activity, high BMI, high 
cholesterol, and hypertension can be contributive risk factors 
to developing T2DM, the researchers wanted to determine the 
distribution and risk factors associated among the ABO blood 
groups in mothers who had GDM. 
 
III.      RESEARCH METHODS 
 
First and foremost, the research design was limited 
to a descriptive study with a cross-sectional approach due to 
the prevailing COVID-19 pandemic situation. Likewise, the 
process of writing this paper was done through online means 
in the respective homes of the researchers, and in accordance 
with the prevailing protocols. This chapter was organized as 
follows: research design, subject and study site, data 
measure/instrumentation, data gathering procedure, ethical 
considerations, and data analysis. The revision did not alter in 
any way the content of this research work. 
3.1. Research Design 
 In order to gather necessary data, this study used a 
quantitative, non-experimental, cross-sectional approach 
which has the capability to provide the following: (a) the 
prevalence of Type 2 diabetes mellitus (T2DM) among 
individuals with a history of Gestational diabetes mellitus 
(GDM), (b) the distribution of the participants in their 
respective ABO blood groups and (c) the associated risk 
factors. This study utilized non-probability purposive 
sampling. The cross-sectional approach involved participants 
based on an inclusion and exclusion criteria applied to the 
study and then the exposure and outcomes for the estimation 
of the prevalence were assessed through odds ratios (Setia, 
2016). With the use of a survey, the data from the participants 
were evaluated and quantified. Thus, the prevalence of T2DM 
was computed and the participants’ blood groups were 
distributed along with the associated risk factors through odds 
ratios.  
 
3.2. Subjects and Study Site 
The researchers determined the population where 
they could get suitable and reliable data. According to the 
study of Duante et al. (2008), there was a higher prevalence 
of individuals with diabetes located in urban areas (7.0%) as 
compared to those who are in the rural areas (5.7%). Thus, the 
study took place in Metro Manila since it was considered as 
an entirely urban location (Philippine Statistics Authority, 
2019). The participants were sourced from Facebook diabetes 
support groups which were considered as the representative 
population of Metro Manila since the members of the groups 
were dispersed throughout the said target location.  
 
From there, an inclusion and exclusion criteria were 
established in order for the data to be reliable and accurate. 
The participants accessed the survey and gave consent to 
provide the needed information for the study. Moreover, the 
individuals were mothers who are 25 to 59 years old with a 
history of GDM living in Metro Manila. The participants had 
to provide a proof of identification and/or residency, as well 
as their proof of GDM and/or T2DM diagnosis. On the other 
hand, nulliparous and nulligravid individuals, mothers who 
did not experience GDM even though they have been 
diagnosed with T2DM, individuals who are under 25 years of 
age and over 59 years of age, and participants living outside 
Metro Manila were excluded from participating in this study. 
In addition, individuals currently diagnosed with other 
diseases except hypertension and high cholesterol were 
excluded in this study. This means individuals such as those 
who have Type 1 diabetes mellitus were also excluded. 
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Lastly, face-to-face interviews were avoided due to the 
restrictions posed by the current public health situation. 
Participants who were unreachable by the online survey were 
also excluded. A withdrawal criterion was also established 
wherein the participants who were hesitant or who had a 
change of mind were free to withdraw their participation as 
long as they have not submitted the survey yet. 
 
The steps for recruitment of respondents are as stated. First, 
the researchers looked into Facebook support groups for 
diabetes patients where there are members who live in Metro 
Manila. These support groups are closed groups that have 
administrators with sufficient knowledge about GDM as well 
as T2DM. To further ensure the suitability of gathering 
respondents from such groups, the groups were checked if 
they are active (the members and administrators are regularly 
sharing relevant posts about GDM, T2DM, and their own 
insights and experiences). Through this, the researchers 
confirmed that the site was suitable enough to gather the 
needed data for the study. The gathered participants answered 
the questions asked by the researchers as they were qualified 
based on the inclusion criteria determined beforehand. In such 
cases where the responses received were perceived as invalid 
as per the exclusion criteria, the researchers filtered these out. 
In determining the sample size, the researchers used 
Cochran’s formula for getting a representative sample for 
proportions. It was determined through the desired level of 
precision, desired level of confidence, and the estimated 
proportion of the attribute present in the population (Cochran, 
1997). It was given by,  
 
Where Z was defined as the z-value derived from the Z table 
with the provided chosen level of significance, p defined as 
the estimated proportion, q is 1-p, and e represented the level 
of precision or the allowed margin of error. In addition, the 
small population sizes were corrected wherein the given value 
above was used. 
 
In the equation above, the said adjusted formula took the total 
population into account which was represented by N. The 
values of the said parameters and the computation of the 
sample size were provided on Table 2. From there, the needed 
survey sample size was calculated to be 302.  
 
Table.2. Sample Size Determination using Cochran’s Formula with Adjustment 
Parameter Value Remarks 





Chosen for maximum variability 
and 
to get a conservatively large 
sample size 
q 0.5  
e 0.05 5% margin of error 
N 1,400 Approx. total population 
n0 384.16  
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3.3. Data Measure/Instrumentation 
The survey tool used in this study was a 
questionnaire made accessible through a Google Forms link. 
The first part consisted of questions which gathered details 
such as name, age, weight, height, and location or address. By 
gathering the participants' information regarding height and 
weight, the researchers calculated the BMI, which was a part 
of the risk factors related to the development of T2DM. From 
the calculated BMI, the participants were classified into four 
groups, namely: below normal weight or underweight, normal 
weight, overweight, and obese (Hariri et al., 2006). The 
second part consisted of questions related to whether the 
participants have been diagnosed with GDM and T2DM. The 
third part gathered participants’ risk factors, such as their 
blood group, their family history of T2DM, if they have 
hypertension, if they have high cholesterol, and their physical 
activity. 
 
The questions regarding physical activity involved estimation 
of the frequency and duration of activities done by the 
participants. These questions regarding the physical activity 
of the participants were adapted from the International 
Physical Activity Questionnaire and scoring protocol (Di 
Blasio et al., 2010). The questionnaire, which was verified by 
authors and made publicly available with open access for 
researchers, provided an appropriate measure of physical 
activity. The participants were asked about their vigorous 
physical activity, moderate physical activity, and the time 
they spent walking and sitting. Based on the scores, physical 
activity was measured as MET-minutes/week, and the 
participants were categorized using the computed scores. This 
questionnaire was used in different research studies such as 
the study published by Sibai and colleagues in 2013, among 
others.  
 
The survey included a part which was adapted from a 
Diabetes Questionnaire used in the study published by Ferrian 
in 2011. However, questions such as additional demographics 
and those about perceptions were not included as they are not 
applicable to the research design. This questionnaire was 
already approved and checked for reliability and validity. The 
survey used in this study consisted of 27 items that were 
answered by the participants for approximately 10 to 20 
minutes. 
 
The researchers used the following: laptops and/or personal 
computers, Microsoft Office applications (Word, Excel, and 
Powerpoint), Google Docs, Google Slides, Google Sheets, 
Google Forms, and R language version 4.0.3. 
 
3.4. Data Gathering Procedure 
Crowdsourcing was the type of sourcing model used 
in this study. The respondents were mothers residing in Metro 
Manila who were diagnosed with GDM. Through the use of 
the internet, the researchers found respondents by 
crowdsourcing and reaching out to Facebook diabetes support 
groups whose members reside in different parts of Metro 
Manila. The researchers coordinated with the administrators 
of the Facebook diabetes support groups.  
 
In this study, the researchers came up with an electronic 
survey questionnaire which aided in gathering data on the 
intended respondents. Through the use of social media, the 
researchers sent out an accessible Google Forms link to the 
participants for the online survey. In this survey, consent 
forms were also attached where the participants can read 
about the purpose and objectives of our study, and give their 
full consent. The survey was cross-checked to ensure that all 
the information asked on the survey was appropriate to be 
answered for the respondents.  
 
The survey also required the respondents to use their personal 
electronic mail for further verification of their information. 
An electronic copy of the participants’ responses was sent to 
their respective electronic mail addresses for their own 
keeping. Lastly, upon hesitance or a change of mind, the 
respondents had the right to withdraw consent from 
participating in this research process before they submitted 
the survey. 
 
The responses collected were subject to the Data Privacy Act 
of 2012. All identities of the respondents and the data 
collected from them through the survey questionnaire were 
not publicly disclosed, rather, they were only internally 
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Fig.3. Research Methodology Workflow 
 
3.5 Ethical Considerations 
 
Ethical approval was obtained from the University 
of Santo Tomas Faculty of Pharmacy Research Ethics 
Committee (USTFOPREC). Compliance to the USTFOPREC 
protocol for the assurance of informed consent and 
respondent confidentiality was guaranteed by the researchers. 
There was no conflict of interest faced by the researchers 
while preparing the study. No specific grant was received nor 
accepted from the University of Santo Tomas, or any agency 
in public or private sectors. 
A brief explanation through online means was given by the 
researchers to the respondents before the distribution of 
consent to confirm that they were aware of the purpose of the 
study, benefits, and risks of participation. The study only 
yielded minimal psychological risk since basic personal and 
medical information were asked from the respondents. To 
counter this risk, confidentiality of information was ensured. 
Respondents were recruited through crowdsourcing in 
Facebook diabetes support groups. The researchers 
coordinated with the group administrators regarding the 
nature of the study prior to data collection. Consent forms 
were sought from respondents before they answered the 
survey questionnaire to ensure their complete voluntary 
participation. For the benefits, this study serves as another 
contribution to their community which gave progress to 
existing studies regarding their condition.  
 
Measures that ensured confidentiality are as follows: names 
of participants were changed to codes to ensure 
confidentiality; personal information were not allowed for 
sharing nor access to third parties; no part of the data was sold 
to anyone; and no part of the participants’ responses were 
reproduced or stored in any retrieval system. After the data 
analysis, the raw electronic data were stored and transferred 
in an encrypted USB device. Only the researchers were able 
to generate a special code to be used in accessing the data 
stored in this device. Disposal of the raw data with personal 
information followed after the entirety of the research by 
means of deleting files permanently and destroying the 
encrypted USB device. 
Processed data or the data that has been grouped and arranged 
for analysis were reported and published accordingly in this 
study. Such data was used for the analysis and for the 
generation of results. No personal identities of the 
respondents were disclosed in any part of this paper. 
However, other researchers may use the processed and 
analyzed data found in this study, as well as the results, if 
found helpful for their own respective research studies. The 
results of this study will be sent to the respective electronic 
mails of the participants. 
 
3.6. Data Analysis 
The statistical techniques utilized by the researchers 
for the data analysis were the computation of the BMI, 
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physical activity, prevalence equation, the odds ratio 
equation, and the logistic regression. 
 
The BMI was computed by dividing the weight in kilograms 
over the height of the individual in meters squared. The 
computed value was used to classify them accordingly for the 
association of the risk of developing T2DM. According to the 
National Health Service (NHS), the ideal BMI for adults was 
18.5 to 24.9. Values below this range were considered 
underweight. Meanwhile, a result within 25-29.9 was 
considered overweight, and a result within 30-39.9 was 
considered obese. The formula for BMI is as stated: 
 
 
Physical activity is a main risk factor measured in this study 
and it was assessed by the researchers through the use of the 
International Physical Activity Questionnaire (IPAQ). The 
questionnaire was inclusive of three different levels of 
physical activity, mainly vigorous, moderate, and leisure 
activities such as walking, their frequency per week, and the 
duration of the activity per day. For this to be measured, the 
total volume of physical activity was calculated by weighing 
the type of each activity defined in METs (3.3 for walking, 
4.0 for moderate physical activity, and 8.0 for vigorous 
physical activity). This was multiplied by the duration of the 
activity in minutes and the frequency of the activity per week 
(number of days in a week). The formulas are as stated below: 
● Walking MET-minutes/week at work = (3.3)(walking 
minutes) (walking days at work) 
 
● Moderate MET-minutes/week at work = 
(4.0)(moderate-intensity activity 
minutes)(moderate-intensity days at work) 
 
● Vigorous MET-minutes/week at work = 
(8.0)(vigorous-intensity activity minutes)(vigorous-
intensity days at work) 
Total Work MET-minutes/week = sum of Walking + Moderate 
+ Vigorous MET-minutes/week scores 
 
After each individual’s scores were computed, the population 
was categorized into three groups: inactive or low physical 
activity, moderately active or moderate, and highly active or 
HEPA (Health Enhancing Physical Activity). A participant 
was categorized as highly active or HEPA, if they have done 
vigorous-intensity activity on >3 days/week while 
accumulating at least 1500 MET-minutes/week; or >7 days of 
any combination of walking, moderate-intensity, or vigorous-
intensity intensity activities achieving at least 3000 MET-
minutes per week. The moderate level of activity 
corresponded to ≥3 days of vigorous-intensity activity of at 
least 20 minutes per day; or ≥5 days of moderate-intensity 
activity and/or walking of at least 30 minutes per day; or ≥5 
days of any combination of walking, moderate-intensity or 
vigorous intensity activities achieving a minimum Total 
physical activity of at least 600 MET-minutes/week. Any 
participant who did not meet the criteria mentioned above for 
both moderate and high categories, were classified as having 
low level of physical activity. 
 
The prevalence computation involved the prediction of the 
percentage of the population who have the specific 
characteristic in a given time period. In this report, the 
prevalence equation was used to calculate the prevalence of 
diagnosed T2DM among mothers who have been diagnosed 
with GDM during their pregnancy. The prevalence equation 




Logistic Regression involved the prediction of a binary 
response variable wherein the prediction equation was framed 
in terms of the probability of an event occurring. That is, the 
link function used, or the function that related the expected 
value of the probability distribution of the response to the 
linear function of the explanatory variables, connecting the 
systematic and random components of a Generalized Linear 
Model (Agresti, 2018), was the logit link. The responses were 





From the above equation, the estimated probability 
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The odds ratio was given by the exponential transformation 
of β where a unit increase in x corresponds to a multiplicative 
effect, eβ, to the odds of success. The results of the final 
logistic regression model were used to characterize the 
significant relationships between the risk factors and blood 
groups, and the probability of developing T2DM. The odds 
ratio measured the association between the risk factors and 
the outcome in that the effect of the presence or absence of a 
factor to that presence or absence of T2DM was quantified. 
These results were put into the context of subsets of the 
population (i.e., in terms of the different blood groups). 
Results were also subjected to hypothesis testing. 
  
IV.     PRESENTATION, ANALYSIS, AND  
INTERPRETATION OF DATA  
 
 Descriptive statistical methods were used to 
present the demographic and overall profile of the 
respondents in terms of the variables measured. This included 
computing for summary statistics with measures of variability 
for continuous variables, as well as frequency and percentage 
distributions for categorical variables. For this study, Body 
Mass Index (BMI) was the only continuous data collected; 
since it was normally-distributed, Means and Standard 
Deviations (SDs) were shown.  
 
Prevalence rates were taken by dividing the number of cases 
with T2DM by the total sample size under consideration. A 
multivariate logistic regression model was fitted to identify 
significant associations between the variables and T2DM 
incidence, and to estimate their effects using Odds Ratios 
(ORs). Two-sided p-values < 0.05 were considered 
statistically significant, and 95% confidence intervals (CIs) 
were calculated for the estimates (sometimes presented as 
estimate ± Margin of Error or MOE = 1.96 * Standard Error 
or SE). Computations were done using version 4.0.3 of the R 




4.1.1. Summary of Respondent Characteristics: 
 
 Survey responses from a total of 302 respondents 
with GDM were collected between April 8, 2021 to June 6, 
2021 after filtering those that met the inclusion/exclusion 
criteria of the study. A total of 148 or 49.01% (95% CI: 
43.25% - 54.79%) were diagnosed with T2DM. 
  
The mean BMI was 26.31 kg/m2 (95% CI: 25.77 - 26.85) 
which is considered overweight by the NHS. The BMI of the 
302 participants ranged from 15.03 kg/m2 to 40.9 kg/m2. Table 
3 presents the characteristics of the T2DM and non-T2DM 
groups, as well as of the overall sample. Comparisons between 
the two groups made use of Student’s t-test for (normally-
distributed) continuous variables, and Pearson’s chi-squared 
test and Fisher’s Exact test (for small frequencies) for 
hypothesis tests for categorical variables. 
 
Majority of the total sample (58.6%) were either Overweight 
(36.4%) or Obese (22.2%). Respondents between the T2DM 
and non-T2DM groups did not have significantly different 
BMIs (p = 0.1605) even when stratified into weight status 
categories. Within the T2DM group, most (37.2%) were in the 
Overweight category, while most (42.9%) were in the Normal 
category for the non-T2DM group.  
 
Almost three-fourths (73.8%) reported having a family history 
of T2DM, while about one-fourth were diagnosed with 
hypertension (26.2%), or were diagnosed with high 
cholesterol (23.5%). Most of the respondents (58.3%) were 
classified as having a low level of physical activity. The 
sample was not symmetrically-distributed across blood 
groups; almost half (45.4%) belonged in Blood Group O, 
Groups A and B equally took about 22%, and Group AB had 
the smallest frequency (11.3%). For these characteristics, all 
hypothesis tests between the T2DM and non-T2DM groups 
were statistically significant (p < 0.05) except for physical 
activity which was only marginally significant (p < 0.10). 
Mothers who developed T2DM were more likely to report a 
family history of the disease (p = 0.0014), and had more 
instances of hypertension (p = 0.0104) and high cholesterol (p 
= 0.0015). The T2DM group also indicated relatively higher 
physical activity levels (High: 14.9% versus 7.1%; overall p = 
0.0799). As with the overall sample, both groups of 
respondents most frequently belonged in Blood Group O and 
least in Group AB, but the non-T2DM group relatively had 
more from Group A (26.0% versus 17.6%); while the T2DM 
group had more from Group B (27.7% versus 15.6%) and 
Blood Group B is the second most frequent phenotype (p = 
0.0402) for this sub-group.
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Table.3. Characteristics of Respondents in the T2DM and non-T2DM groups, and Overall 
Characteristic 
Overall 
(N = 302) 
T2DM Group  




(N = 154, 
50.99%) 
p-value 
BMI in kg/m2 - Mean ± MOE (SD) 
26.31 ± 0.53 
(4.73) 
26.70 ± 0.76 
(4.74) 
25.94 ± 0.74 
(4.71)  
 
  Underweight - N (%) 5 (1.7%) 2 (1.4%) 3 (1.9%)  
  Normal - N (%) 120 (39.7%) 54 (36.5%) 66 (42.9%)  
  Overweight - N (%) 110 (36.4%) 55 (37.2%) 55 (35.7%)  
  Obese - N (%) 67 (22.2%) 37 (25.0%) 30 (19.5%)  
With Family History - N (%) 223 (73.8%) 122 (82.4%) 101 (65.6%) *** 
With High Blood Pressure or Hypertension 
- N (%) 
79 (26.2%) 49 (33.1%) 30 (19.5%) *** 
With High Cholesterol - N (%) 71 (23.5%) 47 (31.8%) 24 (15.6%) *** 
Physical Activity - N (%)     
  Low 176 (58.3%) 85 (57.4%) 91 (59.1%) ** 
  Moderate 93 (30.8%) 41 (27.7%) 52 (33.8%)  
  High 33 (10.9%) 22 (14.9%) 11 (7.1%)  
Blood Group - N (%)     
  A  66 (21.9%) 26 (17.6%) 40 (26.0%) *** 
  B 65 (21.5%) 41 (27.7%) 24 (15.6%)  
  AB 34 (11.3%) 18 (12.2%) 16 (10.4%)  
  O 137 (45.4%) 63 (42.6%) 74 (48.1%)  
*** p-value < 0.05 
** p-value < 0.10 
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 The characteristics of the respondents according to 
ABO blood groups are shown in Table 4. The same statistical 
tests were done for comparisons across the phenotypes except 
for respondents’ BMIs where One-Way Analysis of Variance 
(ANOVA) was done to compare the means. Among the blood 
groups, the risk factors for samples were similar for almost all 
characteristics with largely non-significant p-values and 
distributions that followed the overall trend. A significant 
difference (p = 0.0217) was found, however, in the frequency 
of reported diagnoses of hypertension where Blood Group AB 
had relatively the highest proportion (44.1%) followed by 
groups B (32.3%), O (21.9%), and A (19.7%).
 
Table.4. Characteristics of Respondents by ABO Blood Group 
Characteristic 
A 






(N = 34, 
11.3%) 
O 




BMI in kg/m2 - Mean ± MOE 
(SD) 
26.26 ± 1.12 
(4.62) 
26.22 ± 1.19 
(4.91) 
26.16 ± 1.56 
(4.65) 
26.42 ± 0.80 
(4.76) 
 
  Underweight - N (%) 1 (1.5%) 2 (3.1%) 0 (0.0%) 2 (1.5%)  












  Overweight - N (%) 24 (36.4%) 26 (40.0%) 14 (41.2%) 46 (33.6%)  
  Obese - N (%) 12 (18.2%) 16 (24.6%) 7 (20.6%) 32 (23.4%)  
 
With Family History - N (%) 
 
48 (72.7%) 47 (72.3%) 27 (79.4%) 101 (73.7%)  
With High Blood Pressure or 
Hypertension - N (%) 
13 (19.7%) 21 (32.3%) 15 (44.1%)  30 (21.9%) *** 
With High Cholesterol - N (%) 16 (24.2%) 13 (38.2%) 12 (18.5%) 30 (21.9%)  
Physical Activity - N (%)      
  Low 41 (62.1%) 35 (53.8%) 19 (55.9%) 81 (59.1%)  
  Moderate 20 (30.3%) 22 (33.8%) 10 (29.4%) 41 (29.9%)  
  High 5 (7.6%) 8 (12.3%) 5 (14.7%) 15 (10.9%)  
*** p-value < 0.05      
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4.1.2 T2DM Prevalence across Blood Groups: 
T2DM prevalence rates with 95% CIs across blood 
groups are shown in Table 5. Blood Group B had the highest 
prevalence rate (63.1%) followed by Groups AB (52.9%), O 
(46.0%), and A (39.4%). As shown in Table 3, the Chi-
squared test was significant (p = 0.0402) and indicated that 
there was an association between blood group and T2DM 
incidence. Thus, for the subsequent multivariate regression 
analyses, Blood Group B will be used as the reference 
category for computing the adjusted ORs.
 
Table.5. T2DM Prevalence Rates across Blood Groups  
Blood Group # of with T2DM Prevalence Rate of T2DM (%) 
95% Confidence Intervals 
Lower Upper 
A 26 39.4% 38.3% 40.5% 
B 41 63.1% 61.9% 64.2% 
AB  18 52.9% 50.9% 54.9% 
O 63 46.0% 45.4% 46.6% 
4.1.3 Risk Factor Associations with T2DM 
 The multivariate logistic regression model was 
fitted with T2DM diagnosis as the binary dependent 
variable, and six categorical independent variables 
namely: BMI group, blood group, and diagnosis of 
hypertension, diagnosis of high cholesterol, physical 
activity level, and family history of T2DM.  
 
A Likelihood-Ratio Test (LRT) was conducted to see if 
the difference between the models’ residual deviances 
provided sufficient evidence to consider the simpler 
model over the complex one (Table 6). Upon conducting 
this test, M1 (Model with significant variables only) was 
found to be a better fit with the development of T2DM. A 
model containing all of the predictors (M0) was first fitted, 
followed by a model containing only the significant variables 
(M1).   
 
 The multivariate logistic regression model 
performed in this study was also done in a related study by 
Kugishima et al. (2018) to test for the independent 
relationships between the risk factors in the development of 
diabetes in mothers diagnosed with GDM and the 
development of diabetes itself. 
 
      Table.6. Goodness of Fit of Candidate Models - LRT 
Model Residual Deviance p-value 
M0 (Full Model) 381.27  
M1 (Model with significant variables only) 384.34  
The LRT tests the null hypothesis that the nested model (M1) provides a better fit. With non-significant p-values 
(p = 0.5459), we do not reject the null hypothesis and have no sufficient evidence that the full model (M0) has 
significantly better fit than the simpler model. 
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 The estimates of M1 were chosen to interpret the 
effects of the risk factors to T2DM incidence. To ensure that 
the inferences made were valid, diagnostic checks on this 
model were done, along with additional assessments of model 
adequacy. These can be found in Appendix 8. The Hosmer-
Lemeshow goodness of fit test was not significant (p = 
0.7690) and was unable to detect indications of poor fit. Based 
on the Chi Square statistics where the p-value must be >0.05 
for the model fit of the data to be acceptable. This test was 
also used for confirmation of a fit model in a cross-sectional 
study about the progression of T2DM and its associated risk 
factors after hyperglycemia first detected in pregnancy 
(Chivese, Levit, & Norris, 2019). The model is considered to 
be correctly specified, and is interpreted.  
The regression coefficients and the computed ORs are shown 
in Table 7. BMI group and diagnosis of hypertension were 
both not significant and were excluded from the final model. 
All other predictors had categories that were significant at 
least 0.10 level. 
 
The reference categories were “Low” for physical 
activity level, “Normal” for BMI group, “No” for the 
indicators on family history of T2DM, diagnosed 
hypertension or high cholesterol, and “B” for blood group. 
Mothers with a family history of T2DM were more than twice 
as likely to develop T2DM (OR 2.31, p = 0.0036) than those 
without family history. Progression to T2DM varies widely 
from being diagnosed with GDM during pregnancy. Results 
have shown that diagnosis of high cholesterol increases the 
odds of developing T2DM by almost three times (OR 2.51, p 
= 0.0019).  Having a high level of physical activity had 
marginally significant association with T2DM wherein odds 
were twice as likely than having low physical activity levels 
(OR 2.03, p = 0.0845). Blood Groups A and O showed 
significantly reduced odds of T2DM incidence compared to 
Group B where ORs showed a lower risk as they are 66% and 
55% less likely to develop T2DM, respectively (Group A: OR 
0.34, p = 0.0087; Group O OR 0.45, p = 0.0202).  
 














BMI in kg/m2       
  Underweight -0.177  
0.83 (0.09-
6.23) 
 — — — 
  Normal  (reference)  — — — 
  Overweight 0.003 
1.00 (0.57-
1.76) 
 — — — 
  Obese 0.388 
1.47 (0.77-
2.83) 
 — — — 















 — — — 
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Physical Activity       
  Low  (reference)   (reference)  
  Moderate -0.183 0.83 (0.48-
1.43) 
 -0.165 0.85 (0.50-
1.45) 
 







Blood Group       







  B  (reference)   (reference)  














*** p-value < 0.05 
** p-value < 0.10 
Mo: Full Model 
M1: Model with significant variables only (rows with ‘—’ indicate excluded variables) 
 In Table 8, comparisons between Group B and non-B blood 
groups were also done. Non-B blood group was chosen as the 
reference group because Blood Groups A, AB, and O had all 
decreased risks compared to Blood Group B. Thus, Table 8 
serves as a comparison of the odds of developing T2DM 
between the two blood groups. Mothers in Group B had 
significantly increased odds of developing T2DM, being 2.37 
times as likely as those in non-B groups (p = 0.0044).
 
 Table.8. Summary of Logistic Regression Model for ABO Blood Group Associations with T2DM 
Blood Group 
M1b 
Coefficients OR (95% CI) p-value 
Non-B  (reference)  
B 0.863 2.37 (1.32-4.35) *** 
*** p-value < 0.05 
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 In this study, a total of 302 respondents with GDM 
were collected, and 148 or 49.01% (95% CI: 43.25% - 
54.79%) were diagnosed with T2DM (refer to Table 3). This 
is aligned with the study conducted by Aroda and colleagues 
(2015), stating that women experiencing GDM have about 
50% likelihood of developing T2DM in the ensuing years, 
and may also have recurrent GDM in a subsequent pregnancy. 
 
 The associated risk factors of the respondents (refer to Table 
4) presented were chosen based on the literature found in 
relation to GDM and T2DM. Since, both diseases share 
characteristics with regards to its risk factors and 
mechanisms. In this study, such risk factors were associated 
with ABO blood groups. Groot and colleagues mentioned in 
their 2020 study that ABO blood groups, as well as aging, 
have a role in inheriting and developing diseases. 
 
The results (refer to Table 4) revealed that the blood groups 
and most of the risk factors are not statistically associated 
with each other. However, a significant difference was found 
in the frequency of mothers with a history of GDM that was 
diagnosed with hypertension, especially those that belong in 
Blood Group AB with a proportion of 44.1% followed by 
groups B (32.3%), O (21.9%), and A (19.7%). 
 
Legese, Abebe, and Fasil (2020) also had similar findings 
with the relation of such characteristics wherein family 
history, physical exercise, BMI, Diastolic Blood Pressure, 
TRG, and HDL are not correlated to ABO blood groups (refer 
to Table 4). However, in exception, hypertension was found 
out to be associated with Blood Group AB which has the 
highest proportion of the said condition. This aligned to the 
findings of the aforementioned published study by Legese and 
colleagues wherein hypertension was said to be associated 
with the blood groups. The only difference is that in this 
study, Blood Group AB has the highest proportion of 
diagnosed hypertension. This is in contrast with the study of 
Legese, Abebe, and Fasil (2020) where Blood Group A was 
the most associated blood group with diagnosed hypertension. 
The possible reason for this is the difference in sample size 
and participant criterion, as well as other additional risk 
factors. 
The yielded results (refer to Table 5) were consistent with the 
results of a study by Fagherazzi et al. (2014), that indicated 
that individuals with the Blood Group B had the highest risk 
of developing T2DM compared to other blood groups. The 
same findings were found with the results of the study by 
Legese, Abebe, & Fasil (2020), stating that individuals with 
Blood Group B had the highest risk of developing T2DM. The 
difference in the results from other studies not mentioned may 
be the result of different populations and criteria in both 
studies. 
 
The regression coefficients and the computed ORs are shown 
(refer to Table 7). The BMI group and diagnosis of 
hypertension were both not significant and were excluded 
from the final model in the Likelihood-Ratio Test (LRT). This 
may be because of the limitations brought about by the sample 
size due to the sampling method done. The data gathered from 
the respondents might not be enough to represent the whole 
population of people diagnosed with T2DM with regards to 
BMI and hypertension as its contributing risk factors. 
 
A reference group was needed for the logistic regression 
model in order to compare it from the other groups. In other 
words, the other groups are compared to the reference group. 
A reference group can be chosen from any of the variables 
that are found in the data and no matter what variable is 
chosen, the yielded results will be the same except for the 
resulting p-value. This is usually chosen as the group that 
comes first or last alphabetically, the normative group, has the 
largest group, or the group whose mean is in the middle, or 
conversely, at one of the ends. It does not really matter what 
group is chosen as the reference group as long as it makes the 
most logical sense and makes interpretation of results easier. 
 
In the physical activity level, “Low” was chosen to be the 
reference group to further point out and see the interesting 
comparison of how people differ in terms of level of their 
physical activity since the majority of the respondents 
(58.3%) answered “Low.” Thus, the majority group can be a 
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better option to compare with the minority group levels such 
as the “Moderate” and “High.” For the BMI group, the 
“Normal” category was used because apart from it having the 
highest percentage result, this category pertains to the 
normative group which makes it easier to compare with the 
extremes of the category namely the underweight, 
overweight, and lastly the obese. Indicators on family history 
of T2DM and those diagnosed with hypertension or high 
cholesterol used “No” as the reference category to be able to 
compare it to the one who answered “Yes.”  Finally, for the 
blood group, Blood Group B was used as the reference group 
since it had the highest prevalence rate (63.1%) compared to 
the other blood groups. One of the objectives of this study is 
to identify if a certain major blood group is more significantly 
at risk of developing T2DM after being diagnosed with GDM 
during their pregnancy. Thus, the researchers chose Blood 
Group B that had the highest prevalence rate compared to the 
other blood groups to make the interpretation of the results of 
this study easier. These specific reference groups per category 
were chosen to provide a better understanding on the 
comparison of the yielded data and will not vary if the 
reference groups were changed in terms of interpreting the 
results. 
 
Progression to T2DM varies widely from being diagnosed 
with GDM during pregnancy. Risk factors include race, 
elevated BMI, and family history of T2DM (Rayanagoudar et 
al., 2016). According to Wu et al. (2016), people with first-
degree relatives diagnosed with T2DM have 40% risk of 
inheriting the chronic disease. In addition, the probability of 
having the disease may increase if both or either of the parents 
suffer from the disease. A 2020 study conducted by Feingold 
found that approximately 30-60% of T2DM patients exhibited 
a significant increase in their serum triglyceride, VLDL, and 
IDL cholesterol levels. These observations were found to be 
common since there is a high prevalence and distribution of 
T2DM patients who are normally obese, insulin resistant, and 
have experienced metabolic syndrome. A similar study by 
Kugishima et al. (2018) suggested that women who were 
more obese or with higher BMI (p = 0.0044) had higher risks 
of developing diabetes after pregnancy.  The result (refer to 
Table 7) showed that a high level of physical activity had 
marginally significant association with T2DM wherein odds 
were twice as likely than having low physical activity levels 
(OR 2.03, p = 0.0845).  This result contradicts most of the 
results of similar studies pertaining to the association between 
physical activity and T2DM. Physically inactive individuals 
are at risk of developing T2DM as proved by a study 
conducted among T2DM patients and non-diabetic patients 
(Ahmad et al., 2020). IPAQ or the International Physical 
Activity Questionnaire is a standardized self-reported 
measure of habitual physical activity. Despite having a 
standardized habitual physical activity questionnaire, the 
researchers were not able to closely monitor and instruct how 
the respondents answer the IPAQ. This could be another 
limitation due to the sampling method done in this study. The 
survey conducted was completely done through online means 
so there may be limitations such as having response bias 
which is a tendency for the participants to respond 
inaccurately. However, this just implies that even the mothers 
with high physical activity, as long as there are other risk 
factors present, are still at risk of developing T2DM from 
GDM. 
 
The comparisons of the odds in developing T2DM between 
Group B and non-Group B are presented (refer to Table 8). It 
shows that Mothers in Group B had significantly increased 
odds of developing T2DM, being 2.37 times as likely as those 
in non-B groups (p = 0.0044). The same model is also used 
by Legese, Abebe, & Fasil (2020) which yielded results that 
are aligned with the study. The authors concluded that 
individuals that belong in Blood Group B were 2.12 times 
more at risk in developing T2DM and Blood Group O 
individuals have the least risk in developing the disease. 
However, the aforementioned study included men in their 
participants contrary to this study that only involved women 
with a history of GDM. Another study by Fagherazzi et al. 
(2014) also stated that group Blood Group B showed the 
highest risk of developing T2DM with results of 1.23 (1.09, 
1.38) using the same model compared to the other blood 
groups. The difference was that the reference group of the 
aforementioned study was only Blood Group O while this 
study used all non-B blood groups. 
 
V.    SUMMARY, CONCLUSIONS, AND 
RECOMMENDATIONS  
 
This chapter presents the summary, conclusions 
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This study aimed to determine the prevalence of 
developing Type 2 diabetes mellitus (T2DM) in mothers 
previously diagnosed with Gestational diabetes mellitus 
(GDM). This also discussed the prevalence and distribution 
of T2DM among the different ABO blood groups and its 
associated risk factors. 
 
With these objectives, a descriptive study with a quantitative, 
non-experimental, cross-sectional approach was conducted. 
The sample size was computed using 95% confidence interval 
with a margin of error of 5-10%, and 0.8 power. Three 
hundred and two (302) participants were involved in this 
study. This number was established by using Cochran’s 
formula to derive a representative sample for proportions. The 
participants were then selected using a non-probability 
purposive sampling. The participants were from Facebook 
diabetes support groups and were filtered based on the 
inclusion and exclusion criteria found in Chapter 3. An online 
survey was disseminated to the participants through Google 
Forms along with a consent form to ensure that they 
understood the details of the study. The survey consisted of 
three parts: 1) basic personal information used to calculate the 
Body Mass Index (BMI), 2) questions on whether the 
participants were diagnosed with GDM and T2DM, and 3) 
questions about the risk factors in relation to being diagnosed 
with GDM or T2DM. The data collection was done from 
April 8, 2021 to June 6, 2021. 
 
After the data was acquired from the online survey, the 
researchers used statistical measures namely computation of 
BMI, Means and Standard Deviations of BMI, One-Way 
Analysis of Variance of the BMI, prevalence equation, odds 
ratio, and multivariate logistic regression to analyze data. 
Additionally, statistical tests such as Student’s t-test, 
Pearson's chi-squared test, and Fisher’s Exact test were also 
performed to test the hypotheses. The collected data was 
coded and computed using the R language version 4.0.3 for 
statistical computing. In-depth findings were presented and 
discussed in Chapter 4.  
 
The results of this study revealed that a total of 148 out of 302, 
or 49.01% of mothers who have experienced GDM, have 
developed T2DM. The respondents were characterized based 
on profiles such as BMI, family history of diabetes, having 
high cholesterol or hypertension, blood group, and level of 
physical activity. 
For the BMI, the mean was 26.31 which was interpreted as 
overweight based on the criteria established by the NHS. 
Majority of the respondents (58.6%) were either overweight 
(36.4%) or obese (22.2%). Although there is no significant 
difference between the BMIs of mothers with and without 
T2DM, it is worth noting that the T2DM group were mostly 
overweight (37.2%) while those without T2DM (42.9%) were 
in the normal BMI category. In terms of other risk factors, 
almost three-fourths (73.8%) disclosed having a family 
history of T2DM while almost a quarter (23.5%) revealed to 
have been diagnosed with high cholesterol.  
 
More than a quarter (26.2%) were also revealed to be 
hypertensive or have high blood pressure. Subsequently, the 
blood groups were not equally-distributed with Blood Group 
O dominating almost half (45.4%) of the research population. 
The second most frequent blood group differs between the 
T2DM and non-T2DM groups. In the T2DM group, Blood 
Group B is the second most common phenotype meanwhile 
in non-T2DM group, Blood Group A is the second most 
common phenotype after Blood Group O. With regards to 
physical activity, more than half of the overall sample 
(58.3%) were classified as having low physical activity. 
 
Based on the findings, only family history of diabetes, high 
cholesterol, high physical activity, and blood group were 
significant risk factors in developing T2DM among different 
ABO blood groups. For physical activity, however, it must be 
noted that this risk factor only had a marginal significance in 
association with being diagnosed with T2DM, although it was 
mentioned that the odds of developing T2DM were twice as 
likely in mothers with high physical activity. On the contrary, 
high BMI category, hypertension, and physical inactivity 
were found to be not significant in terms of the development 
of T2DM in mothers who had GDM in relation to the different 
ABO blood groups.  
 
A logistic regression model specifically comparing Blood 
Group B and non-Blood Group B presented in Chapter 4 
showed that Blood Group B can significantly increase the 
odds of developing T2DM. As stated in Chapter 4, mothers 
who are Blood Group B are 2.37 times more likely to have 
T2DM than those who do not belong to the group. 
Furthermore, it has been proven that among different blood 
groups there is a significant variation in the prevalence of the 
development of T2DM.  Blood Group B had the highest 
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prevalence rate (63.1%), then Blood Group AB (52.9%), 
followed by Blood Group O (46.0%), and Blood Group A 
(39.4%). 
 
Mothers in Blood Group B are more at risk of developing 
T2DM especially if they have a family history of T2DM and 
high cholesterol, and even if they have high levels of physical 
activity. This high level of physical activity risk factor is only 
marginally significant as aforementioned. Thus, it does not 
denote that the mothers are automatically at risk if they are 
physically active. The researchers suggest that this finding 
means that even those with high physical activity could also 
be at risk especially if the other two risk factors are present; 
noting that the other two are truly significant. It is also worth 
noting that Blood Group AB, being the second T2DM-
prevalent blood group, had a relatively higher proportion of 
T2DM mothers with hypertension. 
 
5.2. Conclusions 
 In conclusion, the researchers were able to find out 
that there are Filipino mothers that develop T2DM after being 
diagnosed with GDM during pregnancy. Likewise, the 
researchers also arrived at results that show how there are 
different possible risk factors in the development of T2DM in 
mothers after having GDM during pregnancy.  
 
The results of this study along with further research studies 
are beneficial to the diabetic community, allied health 
professionals, people of the academe, and general public, as 
it can raise awareness of the possibilities of developing T2DM 
based on their blood group, as well as the risk factors 
associated with it. The findings can also help health 
professionals to provide monitoring, screening, and 
interventions for patients which is a need during and after 
pregnancy to reduce the risk of progression to T2DM.  
 
5.3. Recommendations 
Based on the findings and conclusions that the 
researchers have arrived at, the following are the suggested 
recommendations: firstly, due to the pandemic, the 
researchers were limited to only using online surveys and 
online interviews to collect data for a limited time - it is 
recommended that future similar studies use a different 
method of sampling which could be through acquisition of 
patient data from actual in and/or out-patients in hospitals or 
clinics, or through big data sourcing from the said institutions. 
For this reason, it is also recommended to have a bigger 
sampling size that would better represent the population. 
Next, it can also be recommended to gather participant 
information from different data points, such as before, during, 
and after pregnancy, to further determine which risk factors 
contribute to the development of T2DM. Regarding such 
recommendations, it is further advised to gather information 
such as BMI, hypertensive status, and other risk factors during 
the recommended different data points. This is a long-term 
research study.  Lastly, a different type of tool may also be 
formulated or used to assess the physical activity of the 
respondents.  
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